Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf
Düsseldorf, 40225, Germany
NCT Number: NCT02728466
There is a question regarding the role of higher flavanol oligomers (procyanidins) and of intestinal flavanol metabolites i.e. valerolactones, in the context of flavanol intake-related vascular effects. Only flavanol monomers, and to a certain degree dimers, are absorbed in the small intestine and enter circulation. Higher oligomers (procyanidins) are not absorbed and are catabolized by the colonic microflora. The catabolites enter the circulation. Phenolic acids and valerolactones represent a significant proportion of these catabolites, reaching peak concentrations in the order of 6-10 h post ingestion. The vascular effects of these colonic microbiome-derived flavanol derivatives have not been studied so far. The purpose of the study is to determine the timecourse of endothelial function along with flavanol catabolites & metabolites during acute, sustained, and acute on sustained ingestion of procyanidins as compared to previously used flavanol interventions, and flavanol free control.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Düsseldorf, 40225, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sustained intake (2x daily over 1 month) of a cocoa-based supplement containing flavanols (monomers) and procyanidins (dimers to decamers)
Sustained intake (2x daily over 1 month) of a cocoa-based supplement containing procyanidins (dimers to decamers)
Placebo comparator: flavanol and procyanidin deprived supplement Sustained intake (2x daily over 1 month) of a macro-and micronutrient matched supplement
Time frame: Baseline and 1 month
Measured by Flow mediated dilation (FMD) at 0 and 2 hours postconsumption on baseline and on 1 month
Time frame: Baseline and 1 month
Measured by high performance liquid chromotography (HPLC) at 2 hours and on 1 month postconsumption
Time frame: Baseline and 1 month
Measured up to 24 hours post consumption on day 1 and 1 month after consumption
Time frame: Baseline and 1 month
Measured up to 24 hours post consumption on day 1 and 1 month after consumption
Time frame: Baseline and 1 month
Measured by SphygmoCor on baseline 2 hours postconsumption and on 1 month.
Time frame: Baseline and 1 month
automatical measurements on baseline 2 hours postconsumption and on 1 month
Time frame: Baseline and 1 month
measured on baseline and after 1 month
Time frame: Baseline and 1 month
measured on baseline and after 1 month
Time frame: Baseline and 1 month
measured on baseline and after 1 month
Time frame: Baseline and 1 month
measured on baseline and after 1 month
Heinrich-Heine University, Duesseldorf
Other
Investigation on the Effects of Cocoa Procyanidins on Vascular Function in Healthy Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details